Koller M R, Emerson S G, Palsson B O
Aastrom Biosciences, Inc, Ann Arbor, MI 48106.
Blood. 1993 Jul 15;82(2):378-84.
There is a growing consensus that clinical practice in the areas of bone marrow (BM) transplantation and gene therapy will rely on the ex vivo expansion of hematopoietic cells. We report here on the development of continuously perfused culture systems (bioreactor systems) that expand human stem and progenitor cells from BM mononuclear cell (MNC) populations obtained without cell enrichment. In three separate experiments, 10 bioreactors were each inoculated with 3 x 10(7) BM MNC from patients undergoing marrow harvest for autologous transplantation. At various times thereafter (between days 6 and 16), duplicate bioreactors were harvested and cells were analyzed. The bioreactors contained three cell populations that were analyzed separately: nonadherent cells; cells that were loosely adherent to the endogenously formed stromal layer; and an adherent cell layer that required trypsinization for removal. Total cell numbers increased continuously to give an overall 10-fold (range, 8- to 11-fold) expansion by day 14. The adherent stromal layer significantly expanded to more than 2 x 10(7) cells, but remained less than 6% of the total cell population. Colony-forming unit-granulocyte-macrophage (CFU-GM) numbers expanded 21-fold (range, 12- to 34-fold) by day 14 and, because this expansion was greater than that for total cells, CFU-GM were enriched by as much as fourfold by day 14. Burst-forming unit-erythroid (BFU-E) numbers peaked earlier than did CFU-GM numbers, with a 12-fold (range, 6- to 18-fold) expansion obtained on day 8. In contrast to CFU-GM, which were predominantly nonadherent, BFU-E were more evenly distributed between the three cell populations. Stem cell activity was measured by the long-term culture-initiating cell (LTC-IC) limiting dilution assay. The number of LTC-IC per reactor consistently increased with time in all cultures, resulting in a 7.5-fold (range, 3.4- to 9.8-fold) expansion. In summary, more than 3 billion cells, containing 12 million CFU-GM, were reproducibly generated from the equivalent of a 10 to 15 ml BM aspirate. These data indicate that small numbers of BM MNC can be readily expanded ex vivo in continuous perfusion cultures, and that such ex vivo expansion may have direct applications in clinical and experimental BM transplantation.
骨髓移植和基因治疗领域的临床实践将依赖于造血细胞的体外扩增,这一共识正在不断增强。我们在此报告连续灌注培养系统(生物反应器系统)的研发情况,该系统可从未经细胞富集获得的骨髓单个核细胞(MNC)群体中扩增人类干细胞和祖细胞。在三个独立实验中,向10个生物反应器分别接种来自接受自体移植骨髓采集患者的3×10⁷个骨髓MNC。此后不同时间点(第6天至第16天之间),对成对的生物反应器进行收获并分析细胞。生物反应器中包含三个分别进行分析的细胞群体:非贴壁细胞;松散贴附于内源性形成的基质层的细胞;以及需要用胰蛋白酶消化才能去除的贴壁细胞层。到第14天,细胞总数持续增加,总体扩增了10倍(范围为8至11倍)。贴壁基质层显著扩增至超过2×10⁷个细胞,但仍占细胞总数的不到6%。集落形成单位 - 粒细胞 - 巨噬细胞(CFU - GM)数量到第14天扩增了21倍(范围为12至34倍),由于这种扩增大于总细胞的扩增,CFU - GM在第14天富集了多达四倍。爆式红系集落形成单位(BFU - E)数量比CFU - GM数量更早达到峰值,在第8天获得了12倍(范围为六至18倍)的扩增。与主要为非贴壁的CFU - GM不同,BFU - E在三个细胞群体中分布更为均匀。通过长期培养起始细胞(LTC - IC)极限稀释分析来测量干细胞活性。每个反应器中LTC - IC的数量在所有培养物中均随时间持续增加,导致扩增了7.5倍(范围为3.4至9.8倍)。总之,从相当于10至15毫升骨髓抽吸物中可重复生成超过30亿个细胞,其中包含1200万个CFU - GM。这些数据表明,少量骨髓MNC可在连续灌注培养中轻松进行体外扩增,并且这种体外扩增可能在临床和实验性骨髓移植中有直接应用。